niacinamide has been researched along with Skin Aging in 25 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Skin Aging: The process of aging due to changes in the structure and elasticity of the skin over time. It may be a part of physiological aging or it may be due to the effects of ultraviolet radiation, usually through exposure to sunlight.
Excerpt | Relevance | Reference |
---|---|---|
"We demonstrated that post-laser topical application of ADSC-CM in combination with niacinamide has anti-aging effect on skin." | 9.41 | Randomized controlled study for the anti-aging effect of human adipocyte-derived mesenchymal stem cell media combined with niacinamide after laser therapy. ( Chung, KB; Kim, J; Kim, S; Lee, JH; Lee, YI, 2021) |
" This formulation also features niacinamide and terminalia chebula to further support the anti-aging benefits of retinol." | 8.12 | Facial Aging Improvement Case Study Using a Novel Combination of Retinol, Niacinamide, and Terminalia Chebula. ( Adams-Woodford, A; Ayres, P; Diaz, I; Giancola, G; Handler, M, 2022) |
"We demonstrated that post-laser topical application of ADSC-CM in combination with niacinamide has anti-aging effect on skin." | 5.41 | Randomized controlled study for the anti-aging effect of human adipocyte-derived mesenchymal stem cell media combined with niacinamide after laser therapy. ( Chung, KB; Kim, J; Kim, S; Lee, JH; Lee, YI, 2021) |
" This formulation also features niacinamide and terminalia chebula to further support the anti-aging benefits of retinol." | 4.12 | Facial Aging Improvement Case Study Using a Novel Combination of Retinol, Niacinamide, and Terminalia Chebula. ( Adams-Woodford, A; Ayres, P; Diaz, I; Giancola, G; Handler, M, 2022) |
"Moreover, NAM reduces skin cancer incidence and prevents the immune-suppressive effects of UV in mice." | 2.61 | Role of Nicotinamide in Genomic Stability and Skin Cancer Chemoprevention. ( Abeni, D; Campione, E; Candi, E; Dellambra, E; Fania, L; Mazzanti, C, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (20.00) | 29.6817 |
2010's | 11 (44.00) | 24.3611 |
2020's | 9 (36.00) | 2.80 |
Authors | Studies |
---|---|
Tan, CYR | 2 |
Tan, CL | 2 |
Chin, T | 2 |
Morenc, M | 1 |
Ho, CY | 1 |
Rovito, HA | 2 |
Quek, LS | 2 |
Soon, AL | 1 |
Lim, JSY | 1 |
Dreesen, O | 1 |
Oblong, JE | 3 |
Bellanger, S | 2 |
Mahajan, AS | 1 |
Arikatla, VS | 1 |
Thyagarajan, A | 1 |
Zhelay, T | 1 |
Sahu, RP | 1 |
Kemp, MG | 1 |
Spandau, DF | 1 |
Travers, JB | 1 |
Rani, S | 1 |
Banik, KB | 1 |
Rath, S | 1 |
Handler, M | 1 |
Adams-Woodford, A | 1 |
Ayres, P | 1 |
Giancola, G | 1 |
Diaz, I | 1 |
Voegeli, R | 1 |
Campiche, R | 2 |
Biassin, R | 1 |
Rawlings, AV | 1 |
Shackelford, TK | 1 |
Fink, B | 1 |
Fania, L | 1 |
Mazzanti, C | 1 |
Campione, E | 1 |
Candi, E | 1 |
Abeni, D | 1 |
Dellambra, E | 1 |
Curpen, SJ | 1 |
Lutchmanen-Kolanthan, V | 1 |
Gougeon, S | 1 |
Cherel, M | 1 |
Laurent, G | 1 |
Gempeler, M | 1 |
Schuetz, R | 1 |
Lee, YI | 1 |
Kim, S | 1 |
Kim, J | 2 |
Chung, KB | 1 |
Lee, JH | 1 |
Flagler, MJ | 1 |
Tamura, M | 1 |
Laughlin, T | 1 |
Hartman, S | 1 |
Ashe, J | 1 |
Adams, R | 1 |
Kozak, K | 1 |
Cresswell, K | 1 |
Mullins, L | 1 |
Jarrold, BB | 1 |
Isfort, RJ | 1 |
Sherrill, JD | 1 |
Nisbet, S | 1 |
Mahalingam, H | 1 |
Gfeller, CF | 1 |
Biggs, E | 1 |
Lucas, S | 1 |
Thompson, M | 1 |
Cargill, MR | 1 |
Moore, D | 1 |
Bielfeldt, S | 1 |
Snaidr, VA | 1 |
Damian, DL | 2 |
Halliday, GM | 1 |
Osborne, R | 1 |
Carver, RS | 1 |
Mullins, LA | 1 |
Finlay, DR | 1 |
Chen, AC | 1 |
Berardesca, E | 1 |
Ardigo, M | 1 |
Cameli, N | 1 |
Mariano, M | 1 |
Agozzino, M | 1 |
Matts, PJ | 1 |
Escudero-Góngora, MM | 1 |
Fernández-Peñas, P | 1 |
Farris, P | 1 |
Zeichner, J | 1 |
Berson, D | 1 |
Barros, BS | 1 |
Zaenglein, AL | 1 |
Kawada, A | 1 |
Konishi, N | 1 |
Oiso, N | 1 |
Kawara, S | 1 |
Date, A | 1 |
Kaczvinsky, JR | 2 |
Griffiths, CE | 1 |
Schnicker, MS | 1 |
Li, J | 2 |
Fu, JJ | 1 |
Hillebrand, GG | 1 |
Raleigh, P | 1 |
Marmor, MJ | 1 |
Bertucci, V | 1 |
Grimes, PE | 1 |
Mandy, SH | 1 |
Perez, MI | 1 |
Weinkle, SH | 1 |
Bissett, D | 1 |
Bissett, DL | 1 |
Berge, CA | 1 |
Chiu, PC | 1 |
Chan, CC | 1 |
Lin, HM | 1 |
Chiu, HC | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Proof of Concept (POC) Clinical Study to Evaluate the Appearance of Fine Lines and Wrinkles on a Developmental Cosmetic Moisturising Cream in Healthy Subjects Presenting Visible Signs of Ageing[NCT03180645] | 72 participants (Actual) | Interventional | 2017-03-20 | Completed | |||
A Proof of Concept (POC) Clinical Study to Investigate the Effects of a Developmental Cosmetic Moisturising Cream on the Barrier Function of Human Skin on the Face and Forearm[NCT03216265] | 69 participants (Actual) | Interventional | 2017-02-23 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Using fringe projection and optical triangulation techniques, the 3D (three dimensional) surface structure of a designated investigational skin site on each side of the face was captured as an in vivo measurement using dermaTOP. From the captured 3D structure, roughness parameters were calculated. Ra is usually used for wrinkle assessments, representing the finer skin structure (Ra). Ra was the average deviation of the profile from the mean line (arithmetic mean of the absolute values of the point's heights). (NCT03180645)
Timeframe: At Baseline and Day 29
Intervention | Micro meter (µm) (Mean) |
---|---|
Test Product | -1.90 |
No Treatment | -0.12 |
Using fringe projection and optical triangulation techniques, the 3D surface structure of a designated investigational skin site on each side of the face was captured as an in vivo measurement using dermaTOP. From the captured 3D structure, roughness parameters were calculated. Ra is usually used for wrinkle assessments, representing the finer skin structure (Ra). Ra was the average deviation of the profile from the mean line (arithmetic mean of the absolute values of the point's heights). (NCT03180645)
Timeframe: At Baseline and Day 15
Intervention | µm (Mean) |
---|---|
Test Product | -0.65 |
No Treatment | -0.18 |
High resolution images of the left and right side of each participant's whole half-face were taken at baseline and Day 29. Each blinded image pair was randomly displayed on a color-calibrated screen and assessed by a panel of lay graders, who ranked each image based on texture, defined as pores, smoothness and unevenness, on a scale of: 1 = better; or 2 = worse (lower score indicated improvement). The total proportion of improvement (from all lay graders) on Day 29 than baseline is reported for this endpoint. (NCT03180645)
Timeframe: At Baseline and Day 29
Intervention | Percent of improvement ratings (Number) |
---|---|
Test Product | 41.49 |
Positive Control | 39.54 |
Negative Control | 40.58 |
A blinded, trained and qualified examiner performed Clinical Fitzpatrick Wrinkle Score assessments by visually grading the crow's feet area under standard conditions of illumination. Fitzpatrick Wrinkle Scores range between 1-9 where 1-3= Fine wrinkles, 4-6= Fine to moderate depth wrinkles, a moderate number of wrinkles, 7-9= Fine to deep wrinkles, numerous lines, with or without redundant skin folds. Low value indicated better results. (NCT03180645)
Timeframe: At Baseline, Day 15 and 29
Intervention | Score on a scale (Mean) | |
---|---|---|
Day 15 | Day 29 | |
No Treatment | -0.15 | -0.22 |
Positive Control | -0.28 | -0.58 |
Test Product | -0.33 | -0.51 |
Measurement of Stratum Corneum (SC) hydration was performed by the electrical capacitance method with a Corneometer. The measuring principle was based on changes in the capacitance of the measuring head, functioning as a condensator. An electric field was created between gold conductors to enable the dielectricity of the SC to be measured. Because the dielectricity varies as a function of the skin's water content, the SC moisturisation was measured. Higher value of corneometery indicates high moisture content. (NCT03180645)
Timeframe: At Baseline, Day 15 and 29
Intervention | Instrumental units (I.U) (Mean) | |
---|---|---|
Day 15 | Day 29 | |
No Treatment | -1.09 | 1.62 |
Positive Control | 7.13 | 10.03 |
Test Product | 6.12 | 8.30 |
The Cutometer measures elasticity of the upper skin layer using negative pressure which deforms the skin mechanically. Negative pressure was created in the device and the skin was drawn into the aperture of the probe and after a defined time released again. Inside the probe, the penetration depth was determined by a non-contact optical measuring system. The light intensity varies due to the penetration depth of the skin. The resistance of the skin to the negative pressure (firmness) and its ability to return into its original position (elasticity) are displayed as curves (penetration depth in mm/time) in real time during the measurement. This measurement principle provides information about the elastic and mechanical properties of the skin surface and enables objective quantification of skin ageing. R7: Portion of the elasticity compared to the complete curve values. (NCT03180645)
Timeframe: At Baseline, Day 15 and 29
Intervention | Ratio (unitless) (Mean) | |
---|---|---|
Day 15 | Day 29 | |
No Treatment | -0.03 | 0.02 |
Positive Control | 0.01 | 0.02 |
Test Product | 0.02 | 0.03 |
The Cutometer measures elasticity of the upper skin layer using negative pressure which deforms the skin mechanically. Negative pressure was created in the device and the skin was drawn into the aperture of the probe and after a defined time released again. Inside the probe, the penetration depth was determined by a non-contact optical measuring system. The light intensity varies due to the penetration depth of the skin. The resistance of the skin to the negative pressure (firmness) and its ability to return into its original position (elasticity) was displayed as curves (penetration depth in mm/time) in real time during the measurement. This measurement principle provides information about the elastic and mechanical properties of the skin surface and enables objective quantification of skin ageing. R5 (net elasticity): the elastic portion of the suction part versus the elastic portion of the relaxation part. (NCT03180645)
Timeframe: At Baseline, Day 15 and 29
Intervention | Ratio (unitless) (Mean) | |
---|---|---|
Day 15 | Day 29 | |
No Treatment | -0.05 | 0.03 |
Positive Control | 0.01 | 0.05 |
Test Product | 0.05 | 0.08 |
Using fringe projection and optical triangulation techniques, the 3D surface structure of a designated investigational skin site on each side of the face was captured as an in vivo measurement using dermaTOP. From the captured 3D structure, roughness parameters were calculated. Ra is usually used for wrinkle assessments, representing the finer skin structure (Ra). Ra is the average deviation of the profile from the mean line (arithmetic mean of the absolute values of the point's heights). (NCT03180645)
Timeframe: At Baseline, Day 15 and 29
Intervention | µm (Mean) | |
---|---|---|
Day 15 | Day 29 | |
No Treatment | -0.18 | -0.12 |
Positive Control | 0.18 | -0.13 |
Using fringe projection and optical triangulation techniques, the 3D surface structure of a designated investigational skin site on each side of the face was captured as an in vivo measurement using dermaTOP. From the captured 3D structure, roughness parameters were calculated. Rz usually used for wrinkle assessments, representing the rough structure, such as wrinkles. Rz was an average of the 5 sub-profiles (peak to valley heights) local maximum. From each local profile the peak to peak height value is calculated; the average of the 5 peak to peak height values was Rz. (NCT03180645)
Timeframe: At Baseline, Day 15 and 29
Intervention | µm (Mean) | |
---|---|---|
Day 15 | Day 29 | |
No Treatment | -1.46 | -1.08 |
Positive Control | 0.97 | -0.55 |
Test Product | -1.92 | -7.01 |
Using fringe projection and optical triangulation techniques, the 3D surface structure of a designated investigational skin site on each side of the face was captured as an in vivo measurement using dermaTOP. The 3D skin surface profile was calculated from the position of the fringes in combination with the Gray values of each pixel. From the captured 3D structure, roughness parameters were calculated. Sa was the arithmetic average of the absolute (non- signed) heights of the topography points. Sa was the 3D Area -Equivalent of 2D profile roughness parameter Ra. (NCT03180645)
Timeframe: At Baseline, Day 15 and 29
Intervention | µm (Mean) | |
---|---|---|
Day15 | Day 29 | |
No Treatment | -0.08 | -0.26 |
Positive Control | 0.17 | -0.21 |
Test Product | -0.60 | -1.83 |
Using fringe projection and optical triangulation techniques, the 3D surface structure of a designated investigational skin site on each side of the face was captured as an in vivo measurement using dermaTOP. The 3D skin surface profile was calculated from the position of the fringes in combination with the Gray values of each pixel. From the captured 3D structure, roughness parameters were calculated. Stm was an average of the 5x5 sub-areas (peak to valley heights) local maximum: The surface was virtually divided into 25 sub-surfaces (5 rows, 5 columns); from each local surface the peak to peak height value is calculated; the average of the 25 peak to height values was Stm. (NCT03180645)
Timeframe: At Baseline, Day 15 and 29
Intervention | µm (Mean) | |
---|---|---|
Day 15 | Day 29 | |
No Treatment | -2.02 | -3.27 |
Positive Control | 5.35 | 0.23 |
Test Product | 5.81 | -12.89 |
TEWL measuring principle was based on water vapour gradient determination between two pairs of sensors (temperature and relative humidity) placed at different distances perpendicularly to the skin. Measurements were taken in triplicate and then an average (mean) reading was calculated on the left and right Sub-ocular/ Cheek Area directly from the corner of the eyes onto the middle of the cheekbone. A decrease in TEWL corresponds to an improved skin barrier function. (NCT03180645)
Timeframe: At Baseline, Day 15 and 29
Intervention | gram (g)/meter^2 (m)/hour (Mean) | |
---|---|---|
Day 15 | Day 29 | |
No Treatment | -2.02 | -3.00 |
Positive Control | -5.98 | -6.62 |
Test Product | -4.17 | -5.18 |
TEWL measuring principle is based on water vapour gradient determination between two pairs of sensors placed at different distances perpendicularly to the skin. The probe was held in place on the skin for one measurement, for approximately 40 secs, to ensure that a stable value has been established. The first part of the measurement belongs to the equilibration phase. The values of the last 10 seconds were averaged as the actual measurement values. An increase in TEWL values shows damage to the skin barrier function. (NCT03216265)
Timeframe: At Baseline and Day 29
Intervention | g/m^2/hour (Mean) |
---|---|
Positive Control | -1.13 |
No Treatment | 0.79 |
TEWL measuring principle is based on water vapour gradient determination between two pairs of sensors placed at different distances perpendicularly to the skin. The probe was held in place on the skin for one measurement, for approximately 40 seconds (sec), to ensure that a stable value has been established. The first part of the measurement belongs to the equilibration phase. The values of the last 10 secs were averaged as the actual measurement values. An increase in TEWL values shows damage to the skin barrier function. (NCT03216265)
Timeframe: At Baseline and Day 29
Intervention | gram (g)/meter(m)^2/hour (Mean) |
---|---|
Test Product | -0.59 |
No Treatment | 0.79 |
TEWL measuring principle is based on water vapour gradient determination between two pairs of sensors placed at different distances perpendicularly to the skin. The probe was held in place on the skin for one measurement, for approximately 40 secs, to ensure that a stable value has been established. The first part of the measurement belongs to the equilibration phase. The values of the last 10 secs were averaged as the actual measurement values. An increase in TEWL values shows damage to the skin barrier function. (NCT03216265)
Timeframe: At Baseline and Day 29
Intervention | g/m^2/hour (Mean) |
---|---|
Test Product | -4.33 |
No Treatment | -3.18 |
The protein content of each D-Squame disc was analysed using a SquameScan. SquameScan is the instrument used to indirectly measure the protein content extracted from the skin by D-squame tape strips. The determination was performed by measuring the optical absorption of the strip at about 850 nanometres (nm) (infrared light). The value displayed in % was proportionally related to the protein content. The protein content was analysed for each of the discs obtained the D-Squame stripping on the forearms and reported to 2 decimal places. (NCT03216265)
Timeframe: On Day 29
Intervention | Percent (Mean) |
---|---|
Test Product | 173.16 |
No Treatment | 213.89 |
The protein content of each D-Squame disc was analysed using a SquameScan. SquameScan is the instrument used to indirectly measure the protein content extracted from the skin by D-squame tape strips. The determination was performed by measuring the optical absorption of the strip at about 850 nm (infrared light). The value displayed in % was proportionally related to the protein content. The protein content was analysed for each of the discs obtained the D-Squame stripping on the face and reported to 2 decimal places. (NCT03216265)
Timeframe: On Day 29
Intervention | percent of absorption (Mean) |
---|---|
Test Product | 84.70 |
No Treatment | 107.75 |
Corneometry was used to measure the moisture content of stratum corneum using corneometer. The measuring principle is based on changes in the capacitance of the measuring head, functioning as a condensator. Between the conductors of the probe an electrical field was built which allows the dielectricity of the stratum corneum to be measured. Because the dielectricity of the skin varies as a function of its water content. The Corneometer measurements were taken 5 times in total and then an average reading was calculated for each site and time point. An increase in corneometry values indicates an increase in the hydration status of the skin and vice versa. (NCT03216265)
Timeframe: At Baseline, Day 30, 31, 32, 33, and 34
Intervention | Corneometry units (Mean) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Day 30, change from baseline, forearm | Day 31,change from baseline, forearm | Day 32,change from baseline, forearm | Day 33,change from baseline, forearm | Day 34,change from baseline, forearm | Day 30,change from baseline, face | Day 31,change from baseline, face | Day 32,change from baseline, face | Day 33,change from baseline, face | Day 34,change from baseline, face | |
No Treatment | 3.48 | 3.54 | 2.25 | 1.54 | 1.99 | 2.35 | 0.76 | 0.41 | -2.38 | 1.09 |
Test Product | 7.11 | 5.51 | 4.25 | 2.85 | 3.53 | 9.68 | 7.40 | 5.93 | 2.93 | 4.76 |
Corneometry was used to measure moisture content of stratum corneum using corneometer. The measuring principle is based on changes in the capacitance of the measuring head, functioning as a condensator. Between the conductors of the probe an electrical field was built which allows the dielectricity of the stratum corneum to be measured. Because the dielectricity of the skin varies as a function of its water content. The Corneometer measurements was taken 5 times in total and then an average reading was calculated for each site and time point. An increase in corneometry values indicates an increase in the hydration status of the skin and vice versa. (NCT03216265)
Timeframe: At Baseline, Day 1 (30 minutes and 6 hours post study product application), Day 2, 15, and 29
Intervention | Corneometry Units (Mean) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Day 1 (30 mins), change from baseline forearm | Day 1 (6 hours), change from baseline, forearm | Day 2, change from baseline, forearm | Day 15, change from baseline, forearm | Day 29, change from baseline, forearm | Day 1 (30 mins) change from baseline, face | Day 1 (6 hours ), change from baseline, face | Day 2, change from baseline, face | Day 15, change from baseline, face | Day 29, change from baseline, face | |
No Treatment | -3.24 | -0.34 | 1.48 | 3.06 | 4.50 | -6.96 | -1.90 | -0.45 | 2.50 | 3.81 |
Test Product | 14.29 | 10.72 | 8.65 | 12.02 | 11.85 | 25.12 | 13.94 | 8.88 | 13.92 | 16.94 |
Standardised AUCday29-34 was calculated for each participant for change from baseline in TEWL on forearms and face over the regression period (Day31, 32, 33 and 34) using the trapezoidal rule and dividing by the number of days in the period. TEWL measuring principle is based on water vapour gradient determination between two pairs of sensors placed at different distances perpendicularly to the skin. The probe was held in place on the skin for one measurement, for approximately 40 secs, to ensure that a stable value was established. The first part of the measurement belongs to the equilibration phase. The values of the last 10 secs were averaged as the actual measurement values. An increase in TEWL values shows damage to the skin barrier function. (NCT03216265)
Timeframe: Up to Day 34
Intervention | g/m^2/hour (Mean) | |
---|---|---|
Change from baseline in AUCday29-34, forearm | Change from baseline in AUCday29-34, face | |
No Treatment | 1.25 | -3.21 |
Positive Control | -0.51 | -4.81 |
Test Product | -0.54 | -3.94 |
TEWL measuring principle is based on water vapour gradient determination between two pairs of sensors placed at different distances perpendicularly to the skin. The probe was held in place on the skin for one measurement, for approximately 40 secs, to ensure that a stable value was established. The first part of the measurement belongs to the equilibration phase. The values of the last 10 secs were averaged as the actual measurement values. An increase in TEWL values shows damage to the skin barrier function. (NCT03216265)
Timeframe: At Baseline, Day 30, 31, 32, 33 and 34
Intervention | g/m^2/hour (Mean) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Day 30, Change from baseline, forearm | Day 31, Change from baseline, forearm | Day 32,Change from baseline, forearm | Day 33,Change from baseline, forearm | Day 34, Change from baseline, forearm | Day 30, Change from baseline, face | Day 31, Change from baseline, face | Day 32, Change from baseline, face | Day 33, Change from baseline, face | Day 34, Change from baseline, face | |
No Treatment | 1.12 | 1.53 | 1.48 | 1.00 | 1.18 | -3.18 | -3.27 | -3.05 | -3.64 | -3.18 |
Test Product | -0.37 | -0.77 | -0.17 | -0.42 | -0.59 | -4.40 | -4.26 | -3.27 | -3.52 | -3.52 |
TEWL measuring principle is based on water vapour gradient determination between two pairs of sensors placed at different distances perpendicularly to the skin. The probe was held in place on the skin for one measurement, for approximately 40 secs, to ensure that a stable value has been established. The first part of the measurement belongs to the equilibration phase. The values of the last 10 secs were averaged as the actual measurement values. An increase in TEWL values shows damage to the skin barrier function. (NCT03216265)
Timeframe: At Baseline, Day 2, and 15
Intervention | g/m^2/hour (Mean) | |||
---|---|---|---|---|
Day 2, change from baseline, forearm | Day 15, change from baseline, forearm | Day 2, change from baseline, face | Day 15, change from baseline, face | |
No Treatment | 0.48 | 1.07 | 0.77 | -2.37 |
Test Product | 0.08 | -0.23 | -1.49 | -4.79 |
Corneometry was used to measure the moisture content of stratum corneum using corneometer. The measuring principle is based on changes in the capacitance of the measuring head, functioning as a condensator. Between the conductors of the probe an electrical field was built which allows the dielectricity of the stratum corneum to be measured. Because the dielectricity of the skin varies as a function of its water content. The Corneometer measurements were taken 5 times in total and then an average reading was calculated for each site and time point. An increase in corneometry values indicates an increase in the hydration status of the skin and vice versa. (NCT03216265)
Timeframe: At Day 29, 30, 31, 32, 33, and 34
Intervention | Corneometry units (Mean) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Day 30, change from Day 29, forearm | Day 31,change from Day 29, forearm | Day 32,change from Day 29, forearm | Day 33,change from Day 29, forearm | Day 34,change from Day 29, forearm | Day 30,change from Day 29, face | Day 31,change from Day 29, face | Day 32,change from Day 29, face | Day 33,change from Day 29, face | Day 34,change from Day 29, face | |
No Treatment | -1.06 | -1.10 | -2.38 | -3.02 | -2.65 | -1.57 | -3.09 | -3.44 | -6.15 | -2.77 |
Test Product | -4.44 | -6.37 | -7.72 | -8.63 | -8.43 | -7.84 | -9.59 | -11.28 | -14.22 | -12.45 |
Standardised AUCday29-34 was calculated for each participant for change from Day 29 in TEWL on forearms and face over the regression period (Day31, 32, 33 and 34) using the trapezoidal rule and dividing by the number of days in the period. TEWL measuring principle is based on water vapour gradient determination between two pairs of sensors placed at different distances perpendicularly to the skin. The probe was held in place on the skin for one measurement, for approximately 40 secs, to ensure that a stable value was established. The first part of the measurement belongs to the equilibration phase. The values of the last 10 secs were averaged as the actual measurement values. An increase in TEWL values shows damage to the skin barrier function. (NCT03216265)
Timeframe: Up to Day 34
Intervention | g/m^2/hour (Mean) | |
---|---|---|
Change from Day 29 in AUCday29-34, forearm | Change from Day 29 in AUCday29-34, face | |
No Treatment | 0.38 | -0.13 |
Positive Control | 0.66 | 0.38 |
Test Product | 0.13 | 0.51 |
TEWL measuring principle is based on water vapour gradient determination between two pairs of sensors placed at different distances perpendicularly to the skin. The probe was held in place on the skin for one measurement, for approximately 40 secs, to ensure that a stable value was established. The first part of the measurement belongs to the equilibration phase. The values of the last 10 secs were averaged as the actual measurement values. An increase in TEWL values shows damage to the skin barrier function. (NCT03216265)
Timeframe: At Day 30, 31, 32, 33, and 34
Intervention | g/m^2/hour (Mean) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Day 30, change from Day 29, forearm | Day 31, change from Day 29, forearm | Day 32, change from Day 29, forearm | Day 33, change from Day 29, forearm | Day 34, change from Day 29, forearm | Day 30, change from Day 29, face | Day 31, change from Day 29, face | Day 32, change from Day 29, face | Day 33, change from Day 29, face | Day 34, change from Day 29, face | |
No Treatment | 0.25 | 0.72 | 0.67 | 0.19 | 0.37 | -0.05 | 0.01 | 0.22 | -0.41 | 0.09 |
Test Product | 0.20 | -0.09 | 0.45 | 0.26 | 0.03 | 0.10 | 0.22 | 1.17 | 1.00 | 0.91 |
A series of D-Squame discs were gently smoothed over the designated D-Squame Areas by applying a uniform pressure for 5 secs with a stamp to ensure consistent adhesion to the skin. Each disc was pulled off the skin with one fluent and decisive movement. There were maximum of 9 D-Squame discs (in groups of 3) removed from the face repeatedly. TEWL measuring principle is based on water vapour gradient determination between two pairs of sensors placed at different distances perpendicularly to the skin. The probe was held in place on the skin for one measurement, for approximately 40 secs, to ensure that a stable value has been established. The first part of the measurement belongs to the equilibration phase. The values of the last 10 secs were averaged as the actual measurement values. TEWL was measured pre-challenge and after 3, 6 and 9 discs have been removed from the face. An increase in TEWL values shows damage to the skin barrier function. (NCT03216265)
Timeframe: On Day 29 (including Pre-challenge)
Intervention | g/m^2/hour (Mean) | |||
---|---|---|---|---|
Pre-challenge Day 29 | Change from pre-challenge after 3 Discs | Change from pre-challenge after 6 Discs | Change from pre-challenge after 9 Discs | |
No Treatment | 14.63 | 6.45 | 16.66 | 27.26 |
Test Product | 13.10 | 4.58 | 11.34 | 20.68 |
A series of D-Squame discs were gently smoothed over the designated D-Squame Areas by applying a uniform pressure for 5 secs with a stamp to ensure consistent adhesion to the skin. Each disc was pulled off the skin with one fluent and decisive movement. There were maximum of 12 D-Squame discs (in groups of 4) removed from each forearm repeatedly. TEWL measuring principle is based on water vapour gradient determination between two pairs of sensors placed at different distances perpendicularly to the skin. The probe was held in place on the skin for one measurement, for approximately 40 secs, to ensure that a stable value has been established. The first part of the measurement belongs to the equilibration phase. The values of the last 10 secs were averaged as the actual measurement values. TEWL was measured pre-challenge and after 4, 8 and 12 discs have been removed from the forearms. An increase in TEWL values shows damage to the skin barrier function. (NCT03216265)
Timeframe: On Day 29 (including Pre-challenge)
Intervention | g/m^2/hour (Mean) | |||
---|---|---|---|---|
Pre-challenge Day 29 | Change from pre-challenge after 4 discs | Change from pre-challenge after 8 discs | Change from pre-challenge after 12 discs | |
No Treatment | 8.33 | 3.06 | 4.94 | 8.46 |
Test Product | 6.96 | 2.60 | 3.35 | 5.56 |
Standardised AUC1-29 was calculated for each participant for change from baseline in corneometry on forearms and face over the treatment period; i.e. up to Day 29 using the trapezoidal rule and dividing by the number of days in the period. Corneometry was used to measure moisture content of stratum corneum using corneometer. The measuring principle is based on changes in the capacitance of the measuring head, functioning as a condensator. Between the conductors of the probe an electrical field was built which allows the dielectricity of the stratum corneum to be measured. Because the dielectricity of the skin varies as a function of its water content. The Corneometer measurements was taken 5 times in total and then an average reading was calculated for each site and time point. An increase in corneometry values indicates an increase in the hydration status of the skin and vice versa. (NCT03216265)
Timeframe: Up to Day 29
Intervention | Corneometry units (Mean) | |
---|---|---|
AUC1-29, Forearm | AUC1-29, Face | |
No Treatment | 2.88 | 2.05 |
Positive Control | 10.20 | 15.90 |
Test Product | 10.87 | 14.03 |
Standardised AUC1-29 was calculated for each participant for change from baseline in TEWL on forearms and face over the treatment period; i.e. up to Day 29 using the trapezoidal rule and dividing by the number of days in the period. TEWL measuring principle is based on water vapour gradient determination between two pairs of sensors placed at different distances perpendicularly to the skin. The probe was held in place on the skin for one measurement, for approximately 40 secs, to ensure that a stable value has been established. The first part of the measurement belongs to the equilibration phase. The values of the last 10 secs were averaged as the actual measurement values. An increase in TEWL values shows damage to the skin barrier function. (NCT03216265)
Timeframe: Up to Day 29
Intervention | g/m^2/hour (Mean) | |
---|---|---|
AUC1-29, Forearm | AUC1-29, Face | |
No Treatment | 0.82 | -1.67 |
Positive Control | -0.42 | -3.21 |
Test Product | -0.30 | -3.95 |
Standardised AUCday29-34 was calculated for each participant for change from baseline in corneometry on forearms and face over the regression period using the trapezoidal rule and dividing by the number of days in the period. Corneometry was used to measure moisture content of stratum corneum using corneometer. The measuring principle is based on changes in the capacitance of the measuring head, functioning as a condensator. Between the conductors of the probe an electrical field was built which allows the dielectricity of the stratum corneum to be measured. Because the dielectricity of the skin varies as a function of its water content. The Corneometer measurements was taken 5 times in total and then an average reading was calculated for each site and time point. An increase in corneometry values indicates an increase in the hydration status of the skin and vice versa. (NCT03216265)
Timeframe: Up to Day 34
Intervention | Corneometry units (Mean) | |
---|---|---|
Change from baseline in AUCday29-34, forearm | Change from baseline in AUCday29-34, face | |
No Treatment | 2.65 | 0.84 |
Positive Control | 4.12 | 7.01 |
Test Product | 4.87 | 7.21 |
Standardised AUCday29-34 was calculated for each participant for change from day 29 in corneometry on forearms and face over the regression period using the trapezoidal rule and dividing by the number of days in the period. Corneometry was used to measure the moisture content of stratum corneum using corneometer. The measuring principle is based on changes in the capacitance of the measuring head, functioning as a condensator. Between the conductors of the probe an electrical field was built which allows the dielectricity of the stratum corneum to be measured. Because the dielectricity of the skin varies as a function of its water content. The Corneometer measurements were taken 5 times in total and then an average reading was calculated for each site and time point. An increase in corneometry values indicates an increase in the hydration status of the skin and vice versa. (NCT03216265)
Timeframe: Up to Day 34
Intervention | Corneometry units (Mean) | |
---|---|---|
Change from Day 29 in AUCday29-34, forearm | Change from Day 29 in AUCday29-34, face | |
No Treatment | -1.81 | -2.99 |
Positive Control | -5.34 | -11.56 |
Test Product | -6.24 | -10.04 |
6 reviews available for niacinamide and Skin Aging
Article | Year |
---|---|
Role of Nicotinamide in Genomic Stability and Skin Cancer Chemoprevention.
Topics: Animals; Energy Metabolism; Genomic Instability; Humans; Immunosuppression Therapy; NAD; Niacinamide | 2019 |
Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety.
Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Chemoprevention; Dermatology; DNA Damage; | 2019 |
Nicotinamide and the skin.
Topics: Acne Vulgaris; Animals; Autoimmune Diseases; Carcinogenesis; Dermatitis, Atopic; Humans; Keratosis, | 2014 |
Nicotinamide: New Indications in Dermatology.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemoprevention; Clinical Trials, Phase III as Topi | 2016 |
The Use of Cosmeceuticals in Acne: Help or Hoax?
Topics: Acne Vulgaris; Complementary Therapies; Contraindications; Cosmeceuticals; Deception; Glycolates; Hu | 2017 |
Topical niacinamide and barrier enhancement.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Epidermis; Facial Dermatoses; Humans; Keratolyt | 2002 |
9 trials available for niacinamide and Skin Aging
Article | Year |
---|---|
Pigmentation effects of blue light irradiation on skin and how to protect against them.
Topics: Administration, Cutaneous; Adult; Double-Blind Method; Female; Humans; Light; Niacinamide; Placebos; | 2020 |
Randomized controlled study for the anti-aging effect of human adipocyte-derived mesenchymal stem cell media combined with niacinamide after laser therapy.
Topics: Adipocytes; Aging; Humans; Laser Therapy; Mesenchymal Stem Cells; Niacinamide; Skin Aging | 2021 |
Cosmetic benefit of a biomimetic lamellar cream formulation on barrier function or the appearance of fine lines and wrinkles in randomized proof-of-concept clinical studies.
Topics: Adolescent; Adult; Aged; Biomimetics; Cosmetics; Female; Humans; Middle Aged; Niacinamide; Permeabil | 2019 |
Cosmetic benefit of a biomimetic lamellar cream formulation on barrier function or the appearance of fine lines and wrinkles in randomized proof-of-concept clinical studies.
Topics: Adolescent; Adult; Aged; Biomimetics; Cosmetics; Female; Humans; Middle Aged; Niacinamide; Permeabil | 2019 |
Cosmetic benefit of a biomimetic lamellar cream formulation on barrier function or the appearance of fine lines and wrinkles in randomized proof-of-concept clinical studies.
Topics: Adolescent; Adult; Aged; Biomimetics; Cosmetics; Female; Humans; Middle Aged; Niacinamide; Permeabil | 2019 |
Cosmetic benefit of a biomimetic lamellar cream formulation on barrier function or the appearance of fine lines and wrinkles in randomized proof-of-concept clinical studies.
Topics: Adolescent; Adult; Aged; Biomimetics; Cosmetics; Female; Humans; Middle Aged; Niacinamide; Permeabil | 2019 |
Randomized, double-blinded, vehicle-controlled, split-face study to evaluate the effects of topical application of a Gold Silk Sericin/Niacinamide/Signaline complex on biophysical parameters related to skin ageing.
Topics: Administration, Topical; Double-Blind Method; Humans; Niacinamide; Pharmaceutical Vehicles; Sericins | 2015 |
Evaluation of anti-wrinkle effects of a novel cosmetic containing niacinamide.
Topics: Administration, Topical; Adult; Cosmetics; Double-Blind Method; Female; Humans; Middle Aged; Niacina | 2008 |
Efficacy of anti-aging products for periorbital wrinkles as measured by 3-D imaging.
Topics: Adult; Aged; Carnosine; Dimethylpolysiloxanes; Double-Blind Method; Female; Glycerol; Humans; Middle | 2009 |
A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen.
Topics: Administration, Topical; Adult; Aged; Cosmetics; Dermatologic Agents; Diterpenes; Emollients; Face; | 2010 |
Niacinamide: A B vitamin that improves aging facial skin appearance.
Topics: Administration, Topical; Adult; Dermatologic Agents; Double-Blind Method; Face; Female; Humans; Midd | 2005 |
The clinical anti-aging effects of topical kinetin and niacinamide in Asians: a randomized, double-blind, placebo-controlled, split-face comparative trial.
Topics: Administration, Cutaneous; Adult; Asian People; Dermatologic Agents; Double-Blind Method; Drug Thera | 2007 |
10 other studies available for niacinamide and Skin Aging
Article | Year |
---|---|
Nicotinamide Prevents UVB- and Oxidative Stress‒Induced Photoaging in Human Primary Keratinocytes.
Topics: Humans; Keratinocytes; Niacinamide; Oxidative Stress; Skin Aging; Ultraviolet Rays | 2022 |
Creatine and Nicotinamide Prevent Oxidant-Induced Senescence in Human Fibroblasts.
Topics: Aged; Cellular Senescence; Creatine; Dermis; Fibroblasts; Humans; Hydrogen Peroxide; Insulin-Like Gr | 2021 |
Formulation and Evaluation of Dermatological Product Containing Niacinamide.
Topics: Humans; Niacinamide; Skin; Skin Aging; Skin Diseases | 2021 |
Facial Aging Improvement Case Study Using a Novel Combination of Retinol, Niacinamide, and Terminalia Chebula.
Topics: Aging; Humans; Niacinamide; Retinoids; Skin Aging; Terminalia; Tretinoin; Vitamin A | 2022 |
Predictors of female age, health and attractiveness perception from skin feature analysis of digital portraits in five ethnic groups.
Topics: Beauty; Caffeine; Ethnicity; Face; Female; Humans; Niacinamide; Perception; Skin; Skin Aging | 2023 |
A Pilot Study to Evaluate the Efficacy and Tolerability of a Topical Combination Serum for the Improvement of Aged Skin.
Topics: Administration, Cutaneous; Aged; Female; Humans; Hyaluronic Acid; Niacinamide; Pilot Projects; Skin | 2023 |
Combinations of peptides synergistically activate the regenerative capacity of skin cells in vitro.
Topics: Cell Line; Drug Synergism; Gene Expression; Humans; Keratinocytes; Niacinamide; Peptides; Rejuvenati | 2021 |
Nicotinamide Metabolism Modulates the Proliferation/Differentiation Balance and Senescence of Human Primary Keratinocytes.
Topics: 3T3 Cells; Acrylamides; Adult; Animals; Cell Differentiation; Cell Proliferation; Cellular Senescenc | 2019 |
Practical application of cellular bioenergetics to the care of aged skin.
Topics: Adult; Cells, Cultured; Collagen Type I; Energy Metabolism; Female; Fibroblasts; Humans; Infant, New | 2013 |
Efficacy and Tolerability of a Skin Brightening/Anti-Aging Cosmeceutical Containing Retinol 0.5%, Niacinamide, Hexylresorcinol, and Resveratrol.
Topics: Administration, Cutaneous; Cosmeceuticals; Drug Combinations; Drug Eruptions; Female; Hexylresorcino | 2016 |